Pranav Garimella is a Nephrology physician affiliated with University of California San Diego. OpenAlex indexes 214 publications with 3,755 citations (h-index 33).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
9452 Medical Center Dr # Mc7424
La Jolla, CA 920371337
Telephone
617-636-8425Provider last certified this registry record 14 Apr 2020.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Otsuka Pharmaceutical Development & Commercialization, Inc.Program year20253 payments
- Travere Therapeutics, Inc.Program year20257 payments
- CALLIDITAS THERAPEUTICS US INC.Program year20243 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
66.2%Calcium channel blocker33.1%Nifedipine Er73%Amlodipine Besylate27%Part D<11 patientsVasopressin V2 Receptor Antagonist14%Jynarque100%Part D<11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
20.6%SGLT2 inhibitor12.5%Jardiance100%Part D<11 patientsCorticosteroid8.1%Prednisone100%Part D<11 patientsCancer & immunology
13.2%Calcineurin inhibitor13.2%Envarsus Xr100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2018–2026 per NIH RePORTER. The latest:
- Kidney Tubular Damage and Dysfunction in Autosomal Dominant Polycystic Kidney Disease
University of California, San Diego
FY2026$656,689R01DK139291 - Kidney Tubular Damage and Dysfunction in Autosomal Dominant Polycystic Kidney Disease
University of California, San Diego
FY2025$690,154R01DK139291 - Kidney Tubular Damage and Dysfunction in Autosomal Dominant Polycystic Kidney Disease
University of California, San Diego
FY2024$649,120R01DK139291
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Robert Weinreb, MD
University of California San Diego
Dilip Jeste, MD
University of California San Diego
Lawrence Eichenfield, MD
University of California San Diego
Stephen Spector, MD
University of California San Diego
Andrew Levey, MD
Tufts Medical Center
Bertram Kasiske, MD
Hennepin Healthcare
Garabed Eknoyan, MD
Baylor College of Medicine
Lawrence Hunsicker, MD
University of Iowa
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”